Data as of Jan 30
| -0.41 / -3.11%|
The 4 analysts offering 12-month price forecasts for Sangamo BioSciences Inc have a median target of 25.00, with a high estimate of 29.00 and a low estimate of 22.00. The median estimate represents a +95.47% increase from the last price of 12.79.
The current consensus among 5 polled investment analysts is to Buy stock in Sangamo BioSciences Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.